Bleeding in patients on concurrent treatment with serotonin reuptake inhibitor (SRI) and acetylsalicylic acid (ASA) compared with ASA alone: a pharmacovigilance study
British Journal of Clinical Pharmacology · 2024
DOI: 10.1111/bcp.16085 ↗Kurz gefasst
Leserbrief in der Zeitschrift British Journal of Clinical Pharmacology, 2024. Verfasst von Jean-Louis Montastruc und 1 weiteren Autor:innen. Beteiligte Einrichtung: Emeritus Professor of Clinical Pharmacology, Toulouse, France. Hauptthemen laut MEDLINE: Selective Serotonin Reuptake Inhibitors, Aspirin, Pharmacovigilance. Die Arbeit nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Emeritus Professor of Clinical Pharmacology, Toulouse, France.
- Department of Vascular Medicine, Toulouse University Hospital, and Department of Medicine, University of Health, Toulouse, France.
ORCID-Profile: Jean-Louis Montastruc, Alessandra Bura-Rivière
Zitieren
APA
Montastruc, J. L., & Bura-Rivière, A. (2024). Bleeding in patients on concurrent treatment with serotonin reuptake inhibitor (SRI) and acetylsalicylic acid (ASA) compared with ASA alone: a pharmacovigilance study. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.16085
Vancouver
Montastruc JL, Bura-Rivière A. Bleeding in patients on concurrent treatment with serotonin reuptake inhibitor (SRI) and acetylsalicylic acid (ASA) compared with ASA alone: a pharmacovigilance study. British Journal of Clinical Pharmacology. 2024. doi:10.1111/bcp.16085
BibTeX
@article{Montastruc2024,
author = {Montastruc, Jean-Louis and Bura-Rivière, Alessandra},
title = {Bleeding in patients on concurrent treatment with serotonin reuptake inhibitor (SRI) and acetylsalicylic acid (ASA) compared with ASA alone: a pharmacovigilance study},
journal = {British Journal of Clinical Pharmacology},
year = {2024},
doi = {10.1111/bcp.16085}
}
EUVIMED